Immunome Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Expected move
Inputs8Q avg ±4.3%·×5.57·rich
straddle ±24.2%
spot 18.21exp Nov 20ATM strike 18ATM straddle 5.18IV 150%
+6.63%
vs ±18.3% implied · ×0.36
shaded = implied · ▲▼ = realized
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | T. Rowe Price Investment ManagementT. Rowe Price | $417.0M | 16.61% | +20.24% | |
| 2 | FMRFMR | $360.0M | 14.34% | +0.10% | |
| 3 | BlackRockBlackRockindex-like | $186.6M | 7.43% | +7.80% | |
| 4 | State StreetState Streetindex-like | $116.4M | 4.64% | +1.75% | |
| 5 | Wellington Management GroupWellington | $110.4M | 4.40% | +10.11% | |
| 6 | Redmile GroupRedmile | $104.1M | 4.15% | −11.64% | |
| 7 | Primecap ManagementPrimecap | $97.1M | 3.87% | −4.32% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $96.4M | 3.84% | +2.74% | |
| 9 | Driehaus Capital ManagementDriehaus | $92.1M | 3.67% | +6.01% | |
| 10 | Enavate Sciences GPEnavate Sciences GP | $76.6M | 3.05% | 0.00% | |
| 11 | Geode Capital ManagementGeodeindex-like | $58.4M | 2.33% | +7.58% | |
| 12 | Morgan StanleyMorgan Stanley | $51.0M | 2.03% | −15.26% | |
| 13 | Silverarc Capital ManagementSilverarc | $42.7M | 1.70% | +9.01% | |
| 14 | JPMorgan ChaseJPMorgan Chase | $39.0M | 1.55% | new | |
| 15 | T. Rowe Price AssociatesT. Rowe Price | $37.6M | 1.50% | −37.97% | |
| 16 | Sofinnova InvestmentsSofinnova | $36.5M | 1.45% | +1.08% | |
| 17 | Readystate Asset ManagementReadystate | $34.0M | 1.36% | +23.35% | |
| 18 | Goldman Sachs GroupGoldman Sachs | $32.0M | 1.28% | +37.31% | |
| 19 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $28.6M | 1.14% | +33.96% | |
| 20 | Principal Financial GroupPrincipal Financial | $28.6M | 1.14% | −2.14% | |
| 21 | BNP Paribas Investment PartnersBNP Paribas Investment Partners | $26.5M | 1.06% | +13.89% | |
| 22 | Woodline PartnersWoodline Partners | $21.2M | 0.84% | −36.50% | |
| 23 | Northern TrustNorthern Trustindex-like | $20.5M | 0.82% | +7.70% | |
| 24 | Charles Schwab Investment ManagementCharles Schwabindex-like | $18.8M | 0.75% | +4.04% | |
| 25 | MetLife Investment AdvisorsMetLife Investment | $18.2M | 0.73% | +1437.99% |
No thesis.
203 managers report $2.5B of Immunome on form 13F for the quarter ended Jun 30 '26. 19 of them hold 80% of it; T. Rowe Price is largest at 16.61%.
Immunome Inc.
18.23